MedPath

Comparison of intranasally given drug dexmedetomidine withintranasal S-keramine for sedation for small procedures in children's emergency department.

Phase 1
Conditions
sedation for emergency procedures
Therapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Anesthesia and Analgesia [E03]
Registration Number
EUCTR2017-000057-40-SE
Lead Sponsor
Karolinska University Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Recruiting
Sex
All
Target Recruitment
30
Inclusion Criteria

Children at the age of 1 - 3 years who present to the emergency
department
- A laceration in need of suturing or burn less than 4% of body surface
area
- Weight 10 – 15 kg
- Previously healthy
- Swedish speaking
Are the trial subjects under 18? yes
Number of subjects for this age range: 52
F.1.2 Adults (18-64 years) no
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

•ASA classification = III (see Supplement 12)
•Current respiratory tract infection
•Impaired level of consciousness
•Hypersensitivity for dexmedetomidine or S-ketamine.
•Further contraindications named in the product resume for the trial
medicines would categorize the patient as ASA III and therefore not
suitable for this trial.
- advanced heart block (grade 2 or 3) unless paced
- uncontrolled hypotension
- acute cerebrovascular conditions.

Study & Design

Study Type
Interventional clinical trial of medicinal product
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath